NEW YORK, Aug. 8 – Orchid Biosciences said on Wednesday its British subsidiary, Cellmark Diagnostics, won a UK-government contract to provide genotyping services to help British farmers breed sheep with increased resistance to scrapie.

Under the terms of the three-year contract, Orchid will use its SNP-IT technology to generate several million scrapie genotypes a year. The contract may be renewed for another two years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.